Biochemical and molecular mechanism for the activation of neurotrophin receptors by Ganglioside GM1
神经节苷脂GM1激活神经营养素受体的生化和分子机制
基本信息
- 批准号:09670648
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Previous studies have shown that neurotrophins such as nerve growth factor (NGF) and their cognate receptors play important roles in the maintainance of neurons in the central and peripheral nervous system. The detailed molecular mechanism of the regulation of neurotrophin receptor, however, remained to be elucidated. Our previous studies have shown that Trk, a high affinity functional receptor for NGF, is regulated positively by endogenous acid glycosphingolipids, ganglioside GM1, by its direct binding to the Trk receptor. In this project, we tried to understand the molecular mechanism for the positve regulation of Trk by GM1 and found the facts listed below ; In the first, rat pheochromocytoma cell line PC12 cells were pre-incubated with various concentrations of D-PDMP, an inhibitor for glucosylceramide synthase activity, for one week in order to deplete cellualr gangliosides including GM1. Then, these cells were stimulated with NGF.To our surprise, these cells failed to respond to NGF in terms of morphological differentiation and the autophosphorylation of the Trk protein. These results strongly indicated that endogenous gangliosides, especially GM1, are indespensable for the normal function of Trk, which further verifys our previous results. In the next, we transfected human trk cDNA into PC12 cells and got a stable transfectant overexpressing Trk protein. Trk-immunoprecipitates from these transfectants were subjected to in-situ V8 proteinase mapping. The results strongly suggested that GM binding sites in the Trk protein reside at the juxtamembrane regions. Confocal laser microscopic examinations and sucrose density ultra-centrifugation examination suggested that Trk is present in the glycolipid-enriched microdomains of the plasma membranes in association wIth GM1.
以往的研究表明,神经营养因子如神经生长因子(NGF)及其同源受体在中枢和外周神经系统神经元的发育中起重要作用。然而,神经营养因子受体调控的详细分子机制仍有待阐明。我们以前的研究表明,Trk,一个高亲和力的功能性受体的神经生长因子,正调控的内源性酸性鞘糖脂,神经节苷脂GM 1,通过其直接结合的Trk受体。本研究试图了解GM 1对Trk正调控的分子机制,发现以下事实:首先,大鼠嗜铬细胞瘤细胞系PC 12细胞与不同浓度的D-Paddy(一种葡萄糖神经酰胺合酶活性抑制剂)预孵育一周,以消耗包括GM 1在内的细胞神经节苷脂。然后,这些细胞与神经生长因子刺激,令人惊讶的是,这些细胞没有响应神经生长因子的形态分化和磷酸化的Trk蛋白。这些结果有力地表明,内源性神经节苷脂,特别是GM 1,是不可缺少的Trk的正常功能,这进一步验证了我们以前的结果。然后将人trk cDNA转染PC 12细胞,获得了稳定表达Trk蛋白的转染细胞。对来自这些转染子的Trk-免疫沉淀物进行原位V8蛋白酶作图。结果表明,GM的Trk蛋白的结合位点位于质膜区域。共聚焦激光显微镜检查和蔗糖密度超离心检查表明,Trk是存在于富含糖脂的微区的质膜与GM 1协会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mutoh T.et al.: "Differential signalling cascade of MAP kinase and S6 kinase deponds on 3', 5'-monophosphate concentration in schwarm cells" Brain Res. 794. 274-278 (1998)
Mutoh T.et al.:“MAP 激酶和 S6 激酶的差异信号级联取决于 schwarm 细胞中的 3, 5-单磷酸浓度”Brain Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
武藤多津郎: "ガングオシドによる神経分化生存の制御機構" 生化学, 5 (1997)
武藤达郎:“甘果苷对神经分化和存活的控制机制”《生物化学》,5(1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mutoh T et al.: "HHG-CoA redactase inhibitor triggers protein tyrosine phosphorylation and subsequent apoptic cell death in Lb myoblasts." FEBS Lett.in press.
Mutoh T 等人:“HHG-CoA 还原酶抑制剂可触发 Lb 成肌细胞中的蛋白质酪氨酸磷酸化和随后的细胞凋亡。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mutoh T et al.: "Role of tyrosine phosphorylation of phospholipase C-g1 in the signal transduction pathway of HMG-CoA reductase inhibitor-induced cell death" FEBS Lett. (in press).
Mutoh T 等人:“磷脂酶 C-g1 酪氨酸磷酸化在 HMG-CoA 还原酶抑制剂诱导细胞死亡的信号转导途径中的作用”FEBS Lett。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Pitto M.et al.: "Influence of endogenous GM1 ganglioside on TrkB activity in cultured cerebellar granule cells" FEBS Lett. 483. 93-96 (1998)
Pitto M.等人:“内源性 GM1 神经节苷脂对培养的小脑颗粒细胞中 TrkB 活性的影响”FEBS Lett。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MUTOH Tatsuro其他文献
MUTOH Tatsuro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MUTOH Tatsuro', 18)}}的其他基金
Membrane rafts impairments in neurological disorders showing dementia
神经系统疾病中的膜筏损伤显示痴呆
- 批准号:
25461295 - 财政年份:2013
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanisms of anti-ganglioside antibody-induced neuronal dysfunction
阐明抗神经节苷脂抗体诱导神经元功能障碍的分子机制
- 批准号:
17590902 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal transduction of neuronal survival and death : cross talk
神经元生存和死亡的信号转导:串扰
- 批准号:
13670637 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Intracellular signal transduction mechanims of neuronal survival and death
神经元生存和死亡的细胞内信号转导机制
- 批准号:
11670616 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal transduction mechanism of cell death-role of kinase cascade.
细胞死亡的信号转导机制——激酶级联的作用。
- 批准号:
07670706 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The study of the intracellular signal transduction pathway for cell proliferation and differentiation - Modulation by gangliosides.
细胞增殖和分化的细胞内信号转导途径的研究——神经节苷脂的调节。
- 批准号:
03670415 - 财政年份:1991
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
从Rho/cofilin通路探讨灵芝三萜联合外源性GM1干预对癫痫后记忆损伤突触重塑机制
- 批准号:81760249
- 批准年份:2017
- 资助金额:34.0 万元
- 项目类别:地区科学基金项目
生物膜中神经节苷脂GM1与淀粉样beta肽的分子作用机理研究
- 批准号:21103043
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
GM1结合NGF对运动神经元再生作用机理的研究
- 批准号:30371550
- 批准年份:2003
- 资助金额:7.0 万元
- 项目类别:面上项目
相似海外基金
血液脳関門を克服するGM1ガングリオシドーシスへの遺伝子治療法の開発
克服血脑屏障的 GM1 神经节苷脂沉积症基因疗法的开发
- 批准号:
24K10959 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Title: Development and Validation of Therapy for GM1 Gangliosidosis
标题:GM1 神经节苷脂沉积症疗法的开发和验证
- 批准号:
10678309 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Validation of analytical methods for quantification of a pentasaccharide biomarker in efficacy assessment of AVV treatment for GM1 gangliosidosis
AVV 治疗 GM1 神经节苷脂沉积症疗效评估中五糖生物标志物定量分析方法的验证
- 批准号:
10599174 - 财政年份:2021
- 资助金额:
$ 1.98万 - 项目类别:
Validation of analytical methods for quantification of a pentasaccharide biomarker in efficacy assessment of AVV treatment for GM1 gangliosidosis
AVV 治疗 GM1 神经节苷脂沉积症疗效评估中五糖生物标志物定量分析方法的验证
- 批准号:
10360564 - 财政年份:2021
- 资助金额:
$ 1.98万 - 项目类别:
Development of a new treatment for Alzheimer's disease targeting GM1 ganglioside
开发针对 GM1 神经节苷脂的阿尔茨海默病新疗法
- 批准号:
18K15369 - 财政年份:2021
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Preclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapy
靶向上皮 GM1 神经节苷脂的口服治疗先导蛋白治疗溃疡性结肠炎的临床前验证
- 批准号:
10596495 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Preclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapy
靶向上皮 GM1 神经节苷脂的口服治疗先导蛋白治疗溃疡性结肠炎的临床前验证
- 批准号:
10055139 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Preclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapy
靶向上皮 GM1 神经节苷脂的口服治疗先导蛋白治疗溃疡性结肠炎的临床前验证
- 批准号:
10198918 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Preclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapy
靶向上皮 GM1 神经节苷脂的口服治疗先导蛋白治疗溃疡性结肠炎的临床前验证
- 批准号:
10379384 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Development of Hematopoietic Stem Targeted Gene Therapy for GM1-gangliosidosis
GM1-神经节苷脂沉积症造血干靶向基因治疗的进展
- 批准号:
18H02783 - 财政年份:2018
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)